BioAlliance Pharma announces the
BioAlliance Pharma SA, the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant of its main patent on the Lauriad® technology in Europe.
aTyr Pharma, the Physiocrine therapeutics company, today announced the formation of a therapeutic advisory board.